Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Mariella G Filbin1,2,3,4,5, Itay Tirosh3,4,6, Volker Hovestadt1,3,4

  • 1Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Science (New York, N.Y.)
|April 21, 2018
PubMed
Summary

Histone H3 lysine27-to-methionine mutations (H3K27M) drive pediatric midline gliomas, which are mainly composed of oligodendrocyte precursor-like cells. These cells show higher proliferation and tumor-propagating potential, suggesting PDGFRA signaling as a therapeutic target.